Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Lannett Company, Inc. with status Current. The shortage was first posted on Jul 14, 2023.
Shortage details
- Status
- Current
- Company
- Lannett Company, Inc.
- Package NDC
- 0527-4664-37
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37)
- Initial Posting
- Jul 14, 2023